Current perspectives on the treatment of nasal polyposis: A swedish opinion report

Acta Oto-Laryngologica

Volumn 122, Issue 7, 2002, Pages 736-744

  Holmström, Mats ^a   Holmberg, K ^b   Lundblad, L ^c   Norlander, T ^d   Stierna, P ^c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d FALUN HOSPITAL   (Sweden)

Author keywords

Antibiotics; Antihistamine; Antileukotrienes; Capsaicin; Corticosteroids; Fungus; Inflammation; Lavage; Polyps; Staging; Surgery

Indexed keywords

ACETYLSALICYLIC ACID; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; AZELASTINE; CAPSAICIN; CETIRIZINE; CLARITHROMYCIN; CORTICOSTEROID; FUROSEMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MACROLIDE; ROXITHROMYCIN; TOBRAMYCIN; ZAFIRLUKAST; ZILEUTON;

ARTICLE; CLINICAL PRACTICE; HUMAN; NOSE POLYP; PRACTICE GUIDELINE; PRIORITY JOURNAL; STAGING; STEROID THERAPY; SWEDEN; TREATMENT INDICATION;

EID: 0036438219     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655402_000028065     Document Type: Article

References (69)

1. Drake-Lee A. The pathogenesis of nasal polyposis. In: Settipane GA, Lund VJ, Bernstein JM, Tos M, eds. Nasal Polyps: Epidemiology, Pathogenesis and Treatment. Providence, RI: OceanSide Publications, 1997: 57-64.
2. Larsen PL, Tos M. Anatomic site of origin of nasal polyps. Endoscopic nasal and paranasal sinus surgery as a screening method for nasal polyps in an autopsy material. Am J Rhinol 1996; 10: 211-6.
3. Van der Baan B. Epidemiology and natural history. In: Mygind N, Lildholt T, eds. Nasal Polyposis. An Inflammatory Disease and its Treatment. Copenhagen: Munksgaard, 1997: 13-6.
4. Slavin RG. Sinusitis in adults and its relation to allergic rhinitis, asthma and nasal polyps. J Allergy Clin Immunol 1988; 82: 950-6.
5. Bernstein JM, Gorfien J, Noble B. Role of allergy in nasal polyposis: A review. Otolaryngol Head Neck Surg 1995; 113: 724-32.
6. Norlander T, Westrin KM, Fukami M, Stierna P, Carlsöö B. Experimentally induced polyps in the sinus mucosa: A structural analysis of the initial stages. Laryngoscope 1996; 106: 196-203.
7. Pang YT, Eskici O, Wilson JA. Nasal polyposis: Role of subclinical delayed food hypersensitivity. Otolaryngol Head Neck Surg 2000; 122: 298-301.
8. Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001; 107: 607-14.
9. Bachert C, Tavernier J, Rudack C, van Cauwenberge P. IL-5 receptor regulation in allergic rhinitis and nasal polyposis. J Allergy Clin Immunol 1998; 101: 250-1.
10. Hamilos DL, Leung DYM, Wood R, et al. Chronic hyperplastic sinusitis. Association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3. J Allergy Clin Immunol 1993; 92: 39-48.
11. Hamilos DL, Leung DYM, Wood R, et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 1995; 96: 537-44.
12. Hamilos DL, Leung DYM, Wood R, et al. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM1 upregulation and expression of TNF-a. Am J Respir Cell Mol Biol 1996; 15: 443-50.
13. Grzegorczyk J, Kowalski ML, Kornatowski T, Pawliczak R. Expression of cyclooxygenase in nasal polyps from atopic and nonatopic subjects. Invest Allergol Clin Immunol 1999; 9: 380-5.
14. Bachert C, Wagenmann M, Rudack C, et al. The role of cytokines in infectious sinusitis and nasal polyposis. Allergy 1998; 53: 2-13.
15. Gilbert JG. Antroscopy in maxillary sinus disease associated with nasal polyposis. J Laryngol Otol 1989; 103: 861-3.
16. Stierna P, Knutsson U, Norlander T, Forsgren K. The role of glucocorticosteroids in sinonasal disease. Infection and inflammation: A vicious circle. In: Veldman JE, Passàli D, Lim DJ, eds. New Frontiers in Immunobiology. The Hague, The Netherlands: Kugler, 2000: 163-8.
17. Malm I. Assessment and staging of nasal polyposis. Acta Otolaryngol (Stockh) 1997; 117: 465-7.
18. Johansson L, Åkerlund A, Holmberg K, Melén I, Stierna P, Bende M. Evaluation of methods for endoscopic staging of nasal polyposis. Acta Otolaryngol 2000; 120: 72-6.
19. Mygind N, Lildholt T. Medical management. In: Settipane G, Lund VJ, Bernstein JM, Tos M, eds. Nasal Polyps: Epidemiology, Pathogenesis and Treatment. Providence, RI: OceanSide Publications, 1997: 147-55.
20. Lildholt T, Dahl R, Mygind N. Effect of corticosteroids. Evidence from controlled trials. In: Mygind N, Lildholt T, eds. Nasal Polyposis. An Inflammatory Disease and its Treatment. Copenhagen: Munksgaard, 1997: 160-9.
21. Hadfield PJ, Rowe-Jones JM, Mackay IS. A prospective trial of nasal polyps in adults with cystic fibrosis. Rhinology 2000; 38: 63-5.
22. Lildholt T, Rundcrantz H, Lindqvist P. Efficacy of topical corticosteroid powder for nasal polyps: A double-blind, placebo-controlled study on budesonide. Clin Otolaryngol 1995; 20: 26-30.
23. Lund VJ, Flood J, Sykes AP, Richards DH. The effect of fluticasone proprionate in severe polyposis. Arch Otolaryngol Head Neck Surg 1998; 124: 513-8.
24. Karlsson G, Rundcrantz H. A randomized trial of intranasal beclomethasone diproprionate after polypectomy. Rhinology 1982; 20: 144-8.
25. Virolainen E, Puhakka H. The effect of intranasal beclomethasone diproprionate on the recurrence of nasal polyps after ethmoidectomy. Rhinology 1980; 18: 9-18.
26. Weber R, Keerl R, Radziwill R, et al. Videoendoscopic analysis of nasal steroid distribution. Rhinology 1999; 37: 69-73.
27. Vento SI, Ertama LO, Hytonen ML, Wolff CHJ, Malmberg CHO. Nasal polyposis: Clinical course during 20 years. Ann Allergy Asthma Immunol 2000; 85: 209-14.
28. Hedén Blomqvist E, Lundblad L, Änggård A, Haraldsson P-O, Stjärne P. A randomized controlled study evaluating medical treatment versus surgical treatment of nasal polyposis. J Allergy Clin Immunol 2001; 107: 224.
29. van Camp P, Clement PAR. Results of oral steroid treatment in nasal polyposis. Rhinology 1994; 32: 5-9.
30. Settipane GA. Nasal polyps. In: Settipane GA, ed. Rhinitis. OceanSide Publications, Inc. Providence, Rhode Island, 1991.
31. Haye R, Aanesen JP, Burtin B, Donnelly F, Duby C. The effect of cetirizine on symptoms and signs of nasal polyposis. J Laryngol Otol 1998; 112: 1042-6.
32. Ulualp SO, Sterman BM, Toohill RJ. Antileukotriene therapy for the relief of sinus symptoms in aspirin triad disease. Ear Nose Throat J 1999; 78: 601-6.
33. Parnes SM, Chuma AV. Acute effects of antileukotrienes on sinonasal polyposis and sinusitis. Ear Nose Throat J 2000; 79: 18-20, 24-5.
34. Mygind N, Dahl R, Bisgaard H. Leukotrienes, leukotriene receptor antagonists, and rhinitis [Review]. Allergy 2000; 55: 421-4.
35. Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: Long-term outcomes. J Allergy Clin Immunol 1996; 98: 751-8.
36. Patriarca G, Bellioni P, Nucera E, et al. Intranasal treatment with lysine acetylsalicylate in patients with nasal polyposis. Ann Allergy 1991; 67: 588-92.
37. Nucera E, Schiavino D, Milani A, et al. Effects of lysine-acetylsalicylate (LAS) treatment in nasal polyposis: two controlled long term prospective follow up studies. Thorax 2000; 55 (Suppl 2): S75-8.
38. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management [Review]. J Allergy Clin Immunol 1999; 104: 5-13.
39. Scadding GK, Hassab M, Darby YC, Lund VJ, Freedman A. Intranasal lysine aspirin in recurrent nasal polyposis. Clin Otolaryngol 1995; 20: 561-3.
40. Blom HM, Van Rijswijk JB, Garrelds IM, Mulder PG, Timmermans T, Gerth van Wijk R. Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis. A placebo-controlled study. Clin Exp Allergy 1997; 27: 796-801.
41. Filiaci F, Zambetti G, Luce M, Ciofalo A. Local treatment of nasal polyposis with capsaicin: Preliminary findings. Allergol Immunopathol (Madr) 1996; 24: 13-8.
42. Zheng C, Wang Z, Lacroix JS. Effect of intranasal treatment with capsaicin on the recurrence of polyps after polypectomy and ethmoidectomy. Acta Otolaryngol 2000; 120: 62-6.
43. Ferrara A, Stortini G, Bellussi L, Di Girolamo S, Zuccarini N, Passali D. Furosemide long-term inhalation therapy in patients with nasal polyposis. Acta Otorhinolaryngol Ital 1994; 14: 633-42 (in Italian).
44. Taccariello M, Parikh A, Darby Y, Scadding G. Nasal douching as a valuable adjunct in the management of chronic rhinosinusitis. Rhinology 1999; 37: 29-32.
45. Majumdar P, Bull PD. The incidence and bacteriology of maxillary sinusitis in nasal polyposis. J Laryngol Otol 1982; 96: 937-41.
46. Dawes P, Bates G, Watson D, Lewis D, Lowe D, Drake-Lee AB. The role of bacterial infection of the maxillary sinus in nasal polyps. Clin Otolaryngol 1989; 14: 447-50.
47. Melén I, Lindahl L, Andreasson L. Short and long-term treatment results in chronic maxillary sinusitis. Acta Otolaryngol (Stockh) 1986; 102: 282-90.
48. Graham SM, Launspach RN, Welsh M, Zarner J. Sequential magnetic resonance imaging analysis of the maxillary sinuses: Implications for a model of gene therapy in cystic fibrosis. J Otol Laryngol 1999; 113: 329-35.
49. Henriksson G, Westrin KM, Kumlien J, Stierna P. A 13-year report on childhood sinusitis: Clinical presentations, predisposing factors and possible means of prevention. Rhinology 1996; 34: 171-5.
50. Meltzer EO, Charous BL, Busse WW, Zinreich J, Lorber RR, Danzig MR. Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray. J Allergy Clin Immunol 2000; 106: 630-7.
51. Nakano T, Ohashi Y, Tanaka A, et al. Roxythromycin reinforces epithelial defence function in rabbit trachea. Acta Otolaryngol Suppl (Stockh) 1998; 538: 34-8.
52. Inamura K, Ohta N, Fukase S, Kasajima N, Aoyagi M. The effects of erythromycin on human peripheral neutrophil apoptosis. Rhinology 2000; 38: 124-9.
53. Nonaka M, Pawankar R, Tomiyama S, Yagi T. A macrolide antibiotic, roxithromycin, inhibits the growth of nasal polyp fibroblasts. Am J Rhinol 1999; 13: 267-72.
54. Ichimura K, Shimazaki Y, Ishibashi T, Higo R. Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis. Auris Nasus Larynx 1996; 23: 48-56.
55. Yamada T, Fujieda S, Mori S, Yamamoto H, Saito H. Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol 2000; 14: 143-8.
56. Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999; 74: 877-84.
57. Sherris DA, Ponikau JU, Kern EB. First Results of Antifungal Therapy in CRS Patients. European Rhinologic Society, Barcelona, 2000: Abstract 478.
58. Mabry RL, Marple BF, Mabry CS. Outcomes after discontinuing immunotherapy for allergic fungal sinusitis. Otolaryngol Head Neck Surg 2000; 122: 104-6.
59. Weber R, Draf W, Keerl R, Schick B, Saha A. Endonasal microscopic pansinus operation in chronic sinusitis. II. Results and complications. Am J Otolaryngol 1997; 18: 247-53.
60. Senior B, Kennedy D, Tanabodee J, Kroger H, Hassab M, Lanza D. Long-term results of functional endoscopic sinus surgery. Laryngoscope 1998; 108: 151-7.
61. Stammberger H. Surgical treatment of nasal polyps: Past, present and future. Allergy 1999; 54 (Suppl): 7-11.
62. Lund VJ, MacKay I. Outcome assessment of endoscopic sinus surgery. J R Soc Med 1994; 87: 70-2.
63. Jankowski R, Pigret D, Decroocq F. Comparison of functional results after ethmoidectomy and nasalization for diffuse and severe nasal polyposis. Acta Otolaryngol (Stockh) 1997; 117: 601-8.
64. Lawson W. The intranasal ethmoidectomy: An experience with 1077 procedures. Laryngoscope 1991; 101: 367-71.
65. Larsen K, Tos M. A long-term follow-up study of nasal polyp patients after simple polypectomies. Eur Arch Otorhinolaryngol 1997; 254 (Suppl. 1): S85-8.
66. Draf W, Weber R, Keerl R, Constantinidis J. Aspects of frontal surgery. Part 1: Endonasal frontal sinus drainage for inflammatory sinus disease. HNO 1995; 43: 352-7.
67. Lildholt T, Rundcrantz H, Bende M, Larsen K. Glucocorticoid treatment for nasal polyps. Arch Otolaryngol Head Neck Surg 1997; 123: 595-600.
68. Dunlop G, Scadding GK, Lund VJ. The effect of endoscopic sinus surgery on asthma: Management of patients with chronic rhinosinusitis, nasal polyposis and asthma. Am J Rhinol 1999; 13: 261-5.
69. Pawlin JD, Colley PS, Weymuller EA Jr, Van Norman G, Gunn HC, Koerschgen ME. Propofol versus isoflurane for endoscopic sinus surgery. Am J Otolaryngol 1999; 20: 96-101.